The role of support measures in the Intensive Care Unit for bone marrow transplant recipients has been controversial. Data from 176 pediatric bone marrow transplants were retrospectively analyzed to ascertain the probability, causes, risk factors and survival for lifethreatening complications requiring intensive care. Ninety-two patients underwent allogeneic BMT and 84 autologous BMT between January 1991 and December 1995. Thirty-one ICU admissions were recorded. The most frequent causes were acute respiratory failure (n = 15, mostly interstitial pneumopathies), septic shock (n = 5) neurological disorders (n = 5) and heart failure (n = 2). The cumulative incidence of an ICU admission at 20 months post-transplant in patients with an allogeneic BMT was 25.7% (CI: 16.4-35.1), compared with 10.8% (CI: 4.2-17.5) in those with an autologous graft (P = 0.04). ICU admission frequency was maximum during the first 2 months post-transplant. All complications in patients with autologous transplants appeared during the first 5 months post-transplant. Among patients with allogeneic grafts, four were later admitted to the ICU, at 7, 9, 12 and 20 months post-transplant, respectively. The main risk factor for ICU admission was acute GVHD grades III-IV. No differences were found between patients with allogeneic transplants with GVHD grades 0-II and those undergoing autologous transplant. In contrast, differences were highly significant between patients undergoing allogeneic transplants with GVHD grades III-IV and those with GVHD grades 0-II or autologous transplants. No differences were observed between allogeneic and autologous transplants in terms of causes for ICU admission, duration of stay, hours on mechanical ventilation, hours on inotropic drug therapy and numbers of organs failing. Neither were differences found in ICU discharge survival between patients with allogeneic (50%, CI: 29.1-70.9) and autologous (66.7%, CI: 29.9-89.1) transplants. ICU discharge survival in patients admitted for lung disease was 28.6% (CI: 12.1-65.6) but 76.5% (CI: 41.9-87.8) in patients admitted for other causes (P = 0.007). ICU Although a complication requiring admission to the ICU is, as confirmed by multivariate analysis, an unfavorable factor in long-term survival of transplanted patients, it must be emphasized that three of every 10 patients admitted to the ICU were alive and well at 3 years. Intensive care support in these patients can be life-saving.
Although a complication requiring admission to the ICU is, as confirmed by multivariate analysis, an unfavorable factor in long-term survival of transplanted patients, it must be emphasized that three of every 10 patients admitted to the ICU were alive and well at 3 years. Intensive care support in these patients can be life-saving. Keywords: bone marrow transplantation; life-threatening complications; intensive care; children Bone marrow transplantation (BMT) has represented a significant advance in the treatment of some malignant and non-malignant diseases which previously had little hope of cure. Nevertheless, the procedure implies certain risks including life-threatening complications, some of which may benefit from supportive intensive care in a specialized unit. Although severe complications have been extensively studied in adults, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] there is a paucity of information on the role of the Intensive Care Unit (ICU) in children. In a recent publication, 27% of the patients admitted to the ICU survived and were discharged from hospital. 12 The outcome in children might not be as poor as in adults. The aims of the present study were: (1) to ascertain the incidence of life-threatening complications requiring ICU admission in BMT patients and the nature of these complications; (2) risk factors involved; and (3) short-and medium-term survival. These aims were studied for the whole transplant population and separately for subgroups of patients undergoing allogeneic or autologous transplantation.
Patients and methods

Study design and patient characteristics
From January 1991 to December 1995, 176 children (116 boys, 60 girls), median age 93.9 months (0.95-257.5) undergoing bone marrow transplantation in a pediatric unit were studied. One hundred and forty-four (82%) had malignant disease (89 acute lymphoblastic leukemia, 41 acute myeloblastic leukemia, 10 non-Hodgkin lymphoma and four chronic myeloid leukemia) and 32 (18%) non-malignant disease (19 aplastic anemia, eight severe combined immunodeficiency, five metabolic inborn errors).
Types of transplants and procedures
Eighty-four (47.7%) were autologous (77 from bone marrow and seven from peripheral blood) and 92 (52.3%) allogeneic (67 from an HLA-identical sibling donor, two syngeneic, 15 from a non-identical relative donor, and eight from unrelated donors).
Conditioning regimens: Conditioning regimens consisted of: total body irradiation (TBI) (14 Gy fractionated in seven sessions) plus cyclophosphamide (CY) (120 mg/kg total dose in 2 days) with or without cytarabine (Ara-C) (8 g/m 2 total dose in 2 days) or etoposide (VPI6) (30 mg/kg total dose in 1 day) in 116 patients (66%), CY plus busulfan (BU) (16 mg/kg total dose in 4 days) with or without Ara-C or VP16 in 36 patients (29%) and other conditioning regimens in 24 (14%).
Infection prophylaxis:
Patients were transplanted in laminar air-flow rooms except for those receiving an autologous peripheral blood transplant who remained in filtered-air rooms. All patients received intestinal decontamination with oral vancomycin and gentamicin, antiviral prophylaxis with acyclovir and antifungal prevention with oral amphoterycin B or fluconazole. Patients undergoing an allogeneic transplant also received weekly i.v. immunoglobulin (400 mg/kg) over the first 3 months post-transplant. Pneumocystis carinii prophylaxis consisted of daily trimethroprim-sulfamethoxazole in all cases starting at hematological recovery. All the hemoderivates administered were filtered.
GVHD prophylaxis:
Of 92 patients with allogeneic transplants, 46 (50%) received prophylaxis with cyclosporin A (CsA) alone, 26 (28%) with CsA and methotrexate (MTX), five with CsA and T cell depletion and 13 received other prophylaxis regimens which included CsA ϩ MTX and T cell depletion or ALG, CsA ϩ monoclonal antibodies (MoAbs) and CsA ϩ prednisone Ϯ MTX. No GVHD prophylaxis was administered to two syngeneic transplants.
Prophylaxis for veno-occlusive disease of the liver: All patients received prophylaxis with continuous i.v. infusion of 100 IU/kg/day heparin for 28 days, from 1 day prior to conditioning to the 21st day post-transplant.
Variables studied
The onset of complications which led to ICU admission, dates of death and last follow-up were registered from the transplant date. There were no strict criteria for ICU admission. Reasons for admission were registered and severity of patient status during ICU stay evaluated according to: (a) number of organ failures (cardiovascular, respiratory, neurologic, gastrointestinal, hepatic, renal and hematopoietic) following the criteria of Wilkinson et al. 13 (b) ICU admission days; (c) hours on mechanical ventilation; and (d) hours on inotropic drugs. The probability of developing a complication requiring ICU admission was established and the influence of the following factors analyzed: type of transplant (autologous or allogeneic), underlying disease (malignant or non-malignant), use of TBI in conditioning regimen and CMV serology prior to transplant. In patients undergoing an allogeneic transplant, degree of acute GVHD (grades 0-II vs grades III-IV) and presence or absence of chronic GVHD were also analyzed. ICU and total survivals defined as discharge from the ICU alive, and survival at 3-years post-ICU admission, respectively, were analyzed.
Mechanical ventilation characteristics
Indications for mechanical ventilation were: (1) Acute respiratory failure with PaO 2 Ͻ60 mmHg with FiO 2 50% or PaCO 2 Ͼ50 mmHg with pH Ͻ7.25. (2) State of shock not responding to volume expanders and inotropic drugs in the first 30 min. (3) Coma with Glasgow score Ͻ9 or р12 with abnormal respiratory pattern.
Servo Ventilator 300 (Siemens-Elema AB, Sweden) and Puritan Bennett 7200 (Puritan-Bennett Corporation, Carlsbad, CA, USA) ventilators were used. In all cases we used volume cycled conventional mechanical ventilation, with a tidal volume of 10-15 ml/kg in an attempt to not exceed a peak inspiratory pressure of 45 cm H 2 O using positive end expiratory pressure levels between 7 and 15 cm H 2 O to maintain PaO 2 Ͼ60 mmHg. In the last 2 years of the study, the permissive hypercapnia technique was used which allowed a PCO 2 of up to 100 mmHg with pH Ͼ7.20.
Statistical analysis
Data were analyzed with the statistical package for social sciences software (SPSS for Windows, Release 6.0, 1993, SPSS Inc, Chicago, IL, USA). Quantitative variables are described by the median, maximum and minimum values. Comparisons of medians of independent groups were analyzed with the Mann-Whitney U test. Qualitative variables were described with percentages in each category and the chi-square test applied for comparisons. Probability of ICU admission and survival was estimated according to the product-limit method (Kaplan-Meier). The log-rank test was used to compare survival curves. Univariate and multivariate analyses were made following the Cox regression model, with results presented as relative risk (RR) and 95% confidence interval (CI). The accepted level of statistical significance was 5%.
Results
Number of ICU admissions and causes
Thirty-one (18%) of a total of 176 transplanted patients were admitted to the ICU. Twenty-two (71%) had undergone allogeneic BMT and nine (29%) autologous transplantation (P = 0.025). Twenty patients had received regimens with TBI ϩ CY Ϯ Ara-C (eight patients) or VP16 (seven patients), eight CY ϩ BU and three CY ϩ total nodal irradiation. The main reasons for ICU admission were acute respiratory failure (ARF) in 15 cases, followed by septic shock, neurological disorders and heart failure. Other causes were acute hemorrhage, veno-occlusive disease (VOD) and anaphylactic shock ( Table 1) . Thirteen of the 15 admissions for ARF were due to interstitial pneumonia. An infectious agent was identified in nine cases: CMV in four, aspergillus in four and Enterococcus faecalis in one.
No infectious cause was found in the remaining four patients. No significant differences were observed in terms of reasons for ICU admission between allogeneic and autologous transplants (Table 1) .
Probability of complications requiring ICU admission
The maximum probability of developing a complication requiring ICU admission occurred over the first 2 months following BMT (Figure 1 ). In the autologous transplant group, all admissions to the ICU occurred in the first 5 months post-transplant. The majority of complications in allogeneic transplants appeared in the first 6 months; however, four patients developed the complication at 7, 9, 12 and 20 months post-transplant, respectively. The probability of developing a complication requiring ICU assistance was 25.7% (CI: of the factors predicting a complication requiring ICU support, only the type of transplant was statistically significant (P = 0.025): patients receiving an allogeneic BMT had a RR of 2.38 (CI: 1.09-5.26) ( Table 2 ). Among the patients receiving an autologous transplant, none of the factors analyzed (underlying disease, TBI in conditioning regimen, CMV positive serology) had statistical value. Acute GVHD intensity was the only statistically significant factor in the group of allogeneic transplants: patients with GVHD grades III and IV had an RR of 4.8 (CI: 2.06-11.23) compared with those with grade 0-II (P Ͻ 0.001) and an RR of 6.17 (CI: 2.58-14.69) compared with the autologous group (P Ͻ 0.001). No differences were found between patients with GVHD grades 0-II and the group of patients receiving an autologous transplant. In the multivariate analysis the allogeneic transplant and, particularly the group of patients with GVHD grades III-IV, again appeared as a risk factor. The underlying disease, type of conditioning regimen and CMV serology did not predict for a higher probability of requiring ICU support ( Table 2) .
Outcome of patients admitted to ICU
Patients admitted to ICU had a median of three organ failures (2-5), 2 days of stay (0.2-26), 43 h of mechanical ventilation (0-740) and 24 h under inotropic drugs (0-285)
. No significant differences were found between the two types of transplant regarding any of the afore-mentioned parameters.
Survival
Univariate and multivariate analysis of the different factors which could influence survival in all transplanted patients revealed significant differences between patients who developed a complication requiring ICU admission and those who did not (RR 5.07; CI 2.64-9.74). Other factors influencing survival were relapse of the underlying disease, graft failure, GVHD grades III and IV and positive CMV serology. Neither the underlying disease nor the type of transplant influenced survival (Table 3) . Overall survival on discharge from ICU was 54.8% (CI: 37.3-72.3). Survival in allogeneic transplant patients was 50% (CI: 29.1-70.9) and 66.7% (CI: 29.9-89.1) in those receiving an autologous transplant, but significant differences were not found. Five of the 31 patients did not require mechanical ventilation and all of them survived. Twenty-six patients underwent mechanical ventilation and ICU survival was 46.2% (CI: 27.0-65.4). Of these 26 patients, 20 had received an allogeneic BMT and six an autologous BMT. Twenty patients had undergone TBI as part of their conditioning regimen; no differences in survival were observed between these patients and those who had not received TBI. Indications for mechanical ventilation, its duration and the outcome in these patients are shown in Table 4 .
Thirteen patients were admitted to the ICU because of interstitial pneumonitis. ICU survival of these patients was 28.6% (CI: 12.1-65.8) vs 76.5% (CI: 41.9-87.8) in patients admitted for other reasons (P = 0.007). Twelve of the 13 required mechanical ventilation; their charateristics are shown in Table 5 . Only two of the 12 survived to the end of the study. NS NS *RR = relative risk; CI = confidence interval; NS = non-significant; BMT = bone marrow transplantation; TBI = total body irradiation; CMV = cytomegalovirus; GVHD = graft-versus-host disease. RR = relative risk; CI confidence interval; NS = non-significant; CMV = cytomegalovirus; GVHD = graft-versus-host disease; ICU = intensive care unit.
Table 4
Characteristics of patients on mechanical ventilation 167 Table 5 Characteristics of mechanically ventilated patients with interstitial pneumonitis
Allogeneic
Autologous Total BMT BMT n = 12 n = 8 n= 4
Infectious etiology 5  3  8  TBI  7  3  10  GVHD III-IV  5  ICU survivors  1  2  3  Long-term survivors  1  1  2 BMI = bone marrow transplantation; TBI = total body irradiation; GVHD = graft-versus-host disease: ICU = intensive care unit.
ICU survival of patients with р3 organ failures was 76.5% (CI: 50.9-92.4) vs 28.6% (CI: 8.4-58.3) in those with Ͼ3 organ failures (P = 0.007). Mortality risk increased 2.7 times with every organ failure. Three-year survival in patients admitted to ICU was 29% (CI: 13.1-45.0) while survival of patients transplanted in the same period who did not require ICU admission was 70.2% (CI: 62.7-77.6) (P Ͻ 0.001) (Figure 2 ).
Discussion
BMT continues to be associated with a high rate of morbidity and mortality. The wide experience acquired in better management of these patients has succeeded in resolving many complications. However, problems that are difficult to treat and overcome continue to appear and the role of ICU in these patients remains controversial. Very few studies have been conducted in children concerning risk of severe complications and the role of ICU. In general, this risk in the adult population ranges from 16% to 40% and mortality from 65% to 97%. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] In one pediatric series, 11% of patients were admitted to the ICU and 27% of those were able to be discharged. 12 In our series, 18% of the transplanted population required ICU admission. The risk was 2.3 times higher in the allogeneic transplant group (25.7% probability in allogeneic BMT vs 10.8% in autologous BMT). The main risk factor related to complications was GVHD grades III and IV. No significant differences were found when patients with an allogeneic transplant and GVHD grades 0-II were compared with patients after autologous transplant. However, differences were highly significant when patients with an allogeneic transplant and GVHD grades III and IV were compared with those with GVHD 0-II and with autologous transplant patients. No correlation was found with underlying disease, conditioning regimen, CMV serology or chronic GVHD. ICU discharge survival was 54.8%, higher than in adult series and the above-mentioned pediatric series. Mortality was higher in allogeneic transplants. However, the differences were not significant (50% in allogeneic BMT and 33.3% in autologous BMT). These results concur with those of other series in which no differences were found in survival between allogeneic and autologous transplants when patients were admitted to ICU.
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Lung complications were the most frequent problems, followed by neurologic disorders and septic shock, with a distribution almost identical to that of the Bristol series. 12 Thirteen patients had interstitial pneumonia: an infectious agent was isolated in nine cases and four were classified as non-infectious. The main pathogens were CMV (four cases) and aspergillus (four cases). No cases of Pneumocystis carinii pneumonia were observed. ICU discharge survival of patients with pneumopathies was 28.6% (CI: 12.1-65.8), much lower than that of patients admitted for other reasons (76.5%; CI: 41.9-87.8; P = 0.007). In the Bristol series, none of the 11 patients with proven viral pneumonitis, and only one of the remaining nine patients with lung injury, survived. 12 Lung disease is confirmed as a poor prognostic factor in survival of these patients.
Twenty-six of the 31 patients admitted to the ICU underwent mechanical ventilation. This represents 83%, a proportion similar to that of the Bristol series (75%). 12 Median duration of mechanical ventilation differed in the two groups: 43 h vs 5 days, respectively. The ICU survival rate in our mechanically ventilated patients was 46.2%, much higher than that of the Bristol group (15%) 12 and other pediatric series (11%).
14 However, only three of the 12 mechanically ventilated patients (25%) with interstitial pneumonitis survived the ICU and two (17%) to the end of the study. Survival, thus, in this group of patients was very poor.
Survival among ventilated patients in adult studies is very low and varies from 0 to 11%. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Some of these series identified older age, longer duration of mechanical ventilation and more severe illness, as measured by organ failure or APACHE (Acute Physiology and Chronic Health Evaluation) score, as poor prognostic factors. Multiorgan failure was also found in most series as a predictor of death. [3] [4] [5] [6] [7] [8] [9] 11, [13] [14] [15] [16] In the present series, the risk of death increased 2.7-fold with every organ failure. Differences in survival between patients with р3 or Ͼ3 organ failures were statistically significant. In recent publications, survival in mechanically ventilated adult patients seems to be improving. In Rubenfeld's series 15 of 3635 BMT performed in 12 years, 909 patients (25%) required mechanical ventilation. No patient who developed combined respiratory failure with hemodynamic, hepatic or renal failure survived.
However, survival improved from 5% in the early years to 16% in the last 5 years and was associated with younger age, low APACHE score and early intubation. Improvement in survival was also confirmed in a recent study by Jackson et al. 16 One hundred and sixteen of 677 bone marrow-transplanted patients required ICU admission; 33% of these and 17% of those on mechanical ventilation were able to be discharged. Prognostic factors were: mechanical ventilation and hemodynamic support and APACHE score Ͼ45. Those authors concluded that despite high mortality, ICU support is beneficial for some patients.
In the recent publication by Warwick et al 17 in 196 patients under 19 years of age who required mechanical ventilation, 40% were extubated successfully, and 1-year survival probability of these 196 patients was 17.6%. These results concur with ours, and are more favorable than those published for adults. These authors conclude that data on outcome in an adult population should not be extrapolated to a pediatric population.
In the present series, univariate and multivariate analyses confirmed ICU admission as a survival-associated risk factor in bone marrow transplant patients. The decision to admit a child to the ICU, given the high mortality rate, remains controversial. However, the fact that three of every 10 patients admitted to the UCI were alive 3 years later suggests that ICU support may be beneficial for critically ill patients.
